Proficio Capital Partners LLC Finch Therapeutics Group, Inc. Transaction History

Proficio Capital Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$12.2 - $16.75 $18,300 - $25,125	-1,500 Reduced 1.34%	110,559 $1.44 Million
Q2 2021 Aug 16, 2021	BUY	$12.03 - $17.51 $1.35 Million - $1.96 Million	112,059 New	112,059 $1.58 Million
Q2 2021 Aug 16, 2021	SELL	$12.03 - $17.51 $1.34 Million - $1.95 Million	-111,559 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$15.54 - $21.32 $1.73 Million - $2.38 Million	111,559 New	111,559 $1.8 Million

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $572M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.